RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal

Danyu Chen1, Fenfen Ji1, Qiming Zhou1

  • 1Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.

Cancer Research
|June 20, 2024
PubMed

Insights

Overexpressed YTHDF1 in colorectal cancer drives resistance. Targeting RUVBL1/2 impairs YTHDF1-driven cancer growth by blocking oncogenic translation, offering a new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • N6-methyladenosine (m6A) RNA-binding protein YTHDF1 is overexpressed in colorectal cancer (CRC), contributing to chemotherapeutic resistance.
  • Identifying novel therapeutic targets in YTHDF1-high CRC is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify druggable targets in YTHDF1-high colorectal cancer.
  • To elucidate the functional and mechanistic roles of RUVBL1 and RUVBL2 in YTHDF1-driven CRC.

Main Methods:

  • CRISPR/Cas9 screening to identify targets.
  • Analysis of patient samples for RUVBL1/2 expression and prognostic value.
  • Functional assays in cancer cells, organoids, and xenografts.
  • Coimmunoprecipitation, mass spectrometry, and ribosome sequencing.
  • Pharmacological inhibition and siRNA-mediated knockdown of RUVBL1/2.

Main Results:

  • CRISPR screening identified RUVBL1 and RUVBL2 as putative targets in YTHDF1-high CRC.
  • RUVBL1/2 are overexpressed in CRC and predict poor prognosis.
  • Loss of RUVBL1/2 selectively inhibits the growth of YTHDF1-high CRC cells, organoids, and xenografts.
  • YTHDF1 and RUVBL1/2 form a feedforward loop promoting oncogenic translation.
  • RUVBL1/2 inhibition via CB6644 or siRNAs arrests YTHDF1-expressing CRC growth.

Conclusions:

  • RUVBL1/2 are potential prognostic markers and druggable targets in YTHDF1-high colorectal cancer.
  • Targeting RUVBL1/2 disrupts YTHDF1-driven oncogenic translation and protein synthesis.
  • RUVBL1/2 inhibition represents a promising therapeutic strategy for YTHDF1-driven colorectal cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K